Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 2051513 | AKOS B018304 | 6308-22-1 | 98% Min. | |
| AKOS B018304 is a potent inhibitor of chikungunya virus with low micro molar activity. | ||||
| 23178 | AC-90179 HCl | 359878-19-6 | 98% Min. |  |
| AC-90179 is a high selective 5-hydroxytryptamine2A receptor inverse agonist. It is an | ||||
| S-203043 | 6-AMINOISOQUINOLINE | 23687-26-5 | 96% Min. |  |
| 204605 | A134974 | 186141-75-3 | 98% Min. |  |
| A134974 is a bioactive chemical. | ||||
| 204604 | A-1293201 | 1375557-33-7 | 98% Min. |  |
| A-1293201 is a potent and selective NAMPT inhibitor. | ||||
| 204603 | A-119637 | 255713-47-4 | 98% Min. |  |
| A-119637 is a novel, selective and potent alpha1D antagonist. | ||||
| 204602 | A-1048400 | 1219624-62-0 | 98% Min. |  |
| A-1048400 is a potent and selective N-type and T-type calcium channel blocker. | ||||
| 204601 | A-1062 | 1821-13-2 | 98% Min. |  |
| A-1062 is a resolvase-binding inhibitor. A1062 inhibits resolvase binding to the res | ||||
| 112193 | AMG-510 | 2296729-00-3 | 98% Min. |  |
| AMG-510 is a potent KRAS G12C covalent inhibitor. AMG-510 selectively targets the KRA | ||||
| 112194 | AMG-510 racemate | 2252403-56-6 | 98% Min. |  |
| AMG-510 is a potent KRAS G12C covalent inhibitor. AMG-510 selectively targets the KRA | ||||
| 112191 | Aprocitentan | 1103522-45-7 | 98% Min. |  |
| Aprocitentan is an orally active, dual endothelin (ET) receptor antagonist developed | ||||
| 6111903 | Aramchol | 246529-22-6 | 98% Min. |  |
| Galmed Pharmaceuticals Announces Successful Completion of End of Phase 2 Meeting With | ||||
| 513191 | Acibenzolar acid | 35272-27-6 | 96% Min. |  |
| benzo[d][1,2,3]thiadiazole-7-carboxylic acid,Acibenzolar acid,CGA 210 007 | ||||
| 193291 | AR-C155858 | 496791-37-8 | >98% |  |
| AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that b | ||||
| 193288 | ACT-709478 | 1838651-58-3 | >98% |  |
| ACT-709478 is a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate | ||||
| 193287 | A1874 | 2064292-12-0 | >98% |  |
| A1874 is a nutlin-based and BRD4-degrading PROTAC which induces BRD4 degradation in c | ||||
| 193254 | AZD9567 | 1893415-00-3 | >98% |  |
| AZD9567 is an oral differentiated non-steroidal selective glucocorticoid receptor mod | ||||
| 193222 | AZ1495 | 2196204-23-4 | >98% |  |
| AZ1495 is a potent and selective IRAK4 inhibitor. | ||||
| 193208 | ATR-101 HCl | 133825-81-7 | >98% |  |
| ATR-101, also known as PD-132301 (a free base) or PD-132301-2 (a HCl salt), is in cli | ||||
| 193192 | ARN-3236 | 1613710-01-2 | >98% |  |
| ARN-3236 is potent, orally active and selective SIK2 inhibitor. ARN-3236 inhibited th | ||||
| 193134 | ARN 077 | 1373625-34-3 | >98% |  |
| ARN 077 is a potent and selective N-acylethanolamine acid amidase (NAAA) inhibitor wi | ||||
| 193125 | Aleglitazar | 475479-34-6 | >98% |  |
| Aleglitazar, also known as RG-1439 or RO-0728804, is a peroxisome proliferator-activa | ||||
| 19382 | Alvimopan | 156053-89-3 | >98% |  |
| Alvimopan, also known as HSDB-7704 and LY246736, is a drug which behaves as a periphe | ||||
| 19381 | Abrocitinib | 1622902-68-4 | >98% |  |
| Abrocitinib, Bulk in stock, contact us by email for the quotation. Kg scale intermedi | ||||
| 19372 | AA26-9 | 1312782-34-5 | >98% |  |
| AA26-9 is a potent and broad-spectrum serine hydrolase inhibitor. AA26-9-inhibited en | ||||
| 19365 | AZD-0284 | 2101291-07-8 | >98% |  |
| AZD-0284 is a potent, selective, inverse agonist of the nuclear receptor RORγ for th | ||||
| 19363 | AZ304 | 942507-42-8 | >98% |  |
| AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type B | ||||
| 19356 | AZ876 | 898800-26-5 | >98% |  |
| AZ876, also known as AZ-876, is a liver X receptor agonist. AZ876 protects against pa | ||||
| 19316 | AGN-190299 | 118292-41-4 | >98% |  |
| Tazarotene is a retinoid prodrug which is converted to its active form, the cognate c | ||||
| 19315 | AM281 | 202463-68-1 | >98% |  |
| AM281 is a synthetic cannabinoid CB1 receptor antagonist. | ||||